| | | | | | |
| | | | Six Months Ended June 30, |
| | Note | | 2025 | | 2024 |
Revenue | | | | | | |
Goods —third parties | | | | 199,364 | | 204,574 |
—related parties | | 17(i) | | 727 | | 2,002 |
Services —commercialization—third parties | | | | 19,985 | | 28,222 |
—research and development—related parties | | 17(i) | | — | | 236 |
—collaboration research and development—third parties | | | | 14,201 | | 35,740 |
Other collaboration revenue | | | | | | |
—royalties—third parties | | | | 31,310 | | 34,907 |
—licensing—third parties | | | | 12,090 | | — |
Total revenue | | 14 | | 277,677 | | 305,681 |
Operating expenses | | | | | | |
Cost of goods—third parties | | | | (147,601) | | (151,681) |
Cost of goods—related parties | | | | (391) | | (987) |
Cost of services—commercialization—third parties | | | | (19,585) | | (27,467) |
Research and development expenses | | 15 | | (71,990) | | (95,256) |
Selling expenses | | | | (13,873) | | (27,351) |
Administrative expenses | | | | (27,751) | | (30,460) |
Total operating expenses | | | | (281,191) | | (333,202) |
| | | | (3,514) | | (27,521) |
Gain on divestment of an equity investee | | 16 | | 477,456 | | — |
Other income, net | | | | 21,650 | | 22,765 |
Income/(loss) before income taxes and equity in earnings of an equity investee | | | | 495,592 | | (4,756) |
Income tax expense | | 18 | | (63,162) | | (2,886) |
Equity in earnings of an equity investee, net of tax | | 7 | | 23,125 | | 33,807 |
Net income | | | | 455,555 | | 26,165 |
Less: Net income attributable to non-controlling interests | | | | (601) | | (364) |
Net income attributable to the Company | | | | 454,954 | | 25,801 |
Earnings per share attributable to the Company (US$ per share) | | | | | | |
—basic | | 19 | | 0.53 | | 0.03 |
—diluted | | 19 | | 0.52 | | 0.03 |
Number of shares used in per share calculation | | | | | | |
—basic | | 19 | | 857,038,725 | | 856,030,704 |
—diluted | | 19 | | 872,564,513 | | 872,534,466 |